Percutaneous left atrial appendage closure devices: safety, efficacy, and clinical utility
Martin J Swaans, Lisette IS Wintgens, Arash Alipour, Benno JWM Rensing, Lucas VA Boersma Department of Cardiology, St. Antonius Hospital, Nieuwegein, the Netherlands Abstract: Atrial fibrillation (AF) is the most common arrhythmia treated in the clinical practice...
Enregistré dans:
Auteurs principaux: | Swaans MJ, Wintgens LIS, Alipour A, Rensing BJWM, Boersma LVA |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2016
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/ed823a8e7f95473ea469f7adf5ad2ff8 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Periprocedural and Short‐Term Outcomes of Percutaneous Left Atrial Appendage Closure According to Type of Atrial Fibrillation
par: Toshiaki Isogai, et autres
Publié: (2021) -
Long-term effect of anticoagulation following left atrial appendage occlusion with the LARIAT device in patients with nonvalvular atrial fibrillation: impact on thromboembolism, bleeding and mortality. Real life data
par: Radosław Litwinowicz, et autres
Publié: (2020) -
Risk factors of left atrial appendage thrombus in patients with non-valvular atrial fibrillation
par: Liu Yaowu, et autres
Publié: (2021) -
Five-Year Outcomes and Cardiac Remodeling Following Left Atrial Appendage Occlusion
par: Liu B, et autres
Publié: (2021) -
Patient-specific flow simulation analysis to predict device-related thrombosis in left atrial appendage occluders
par: Jordi Mill, et autres
Publié: (2021)